Elevated Levels of IL-10 and G-CSF Associated with Asymptomatic Malaria in Pregnant Women
暂无分享,去创建一个
F. Shuaib | A. Adjei | Tameka Bythwood | Nana O. Wilson | J. Stiles | P. Jolly | Wesley Solomon | Yi Jiang | N. Yatich | Winston A. Anderson
[1] J. Rayner,et al. Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors. , 2009, The American journal of tropical medicine and hygiene.
[2] R. Snow,et al. Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children , 2008, PloS one.
[3] R. Ned,et al. Malaria Journal Plasma Ip-10, Apoptotic and Angiogenic Factors Associated with Fatal Cerebral Malaria in India , 2008 .
[4] J. Kurtis,et al. Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria , 2008, Malaria Journal.
[5] Venkatachalam Udhayakumar,et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children , 2007, Malaria Journal.
[6] V. do Rosário,et al. Epidemiological characterization of Plasmodium falciparum in the Republic of Cabo Verde: implications for potential large-scale re-emergence of malaria , 2006, Malaria Journal.
[7] David L Smith,et al. Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant Malaria , 2006, PLoS medicine.
[8] M. T. Marrelli,et al. Asymptomatic Carriers of Plasmodium spp. as Infection Source for Malaria Vector Mosquitoes in the Brazilian Amazon , 2005, Journal of medical entomology.
[9] V. Titanji,et al. Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. , 2005, The American journal of tropical medicine and hygiene.
[10] M Tanner,et al. A prospective study of Plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] O. Doumbo,et al. Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium falciparum Malaria and Matched Uncomplicated Malaria or Healthy Controls , 2004, Infection and Immunity.
[12] G. Dorsey,et al. Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children , 2004, Tropical medicine & international health : TM & IH.
[13] C. Drakeley,et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya , 2004, Malaria Journal.
[14] B. Knols,et al. Infectivity of Plasmodium falciparum gametocytes in patients attending rural health centres in western Kenya. , 2004, East African medical journal.
[15] Z. Premji,et al. Higher IL‐10 levels are associated with less effective clearance of Plasmodium falciparum parasites , 2004, Parasite immunology.
[16] Ainong Zhou,et al. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. , 2003, The American journal of tropical medicine and hygiene.
[17] G. Fouda,et al. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. , 2003, The Journal of infectious diseases.
[18] B. Lell,et al. Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] M. Alifrangis,et al. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker , 2003, Malaria Journal.
[20] B. Lell,et al. New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. , 2002, The American journal of tropical medicine and hygiene.
[21] C. Wongsrichanalai,et al. Histidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing , 2002, Antimicrobial Agents and Chemotherapy.
[22] D McGuinness,et al. Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. , 2001, The Journal of infectious diseases.
[23] B. Lell,et al. Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. , 2000, The Journal of infectious diseases.
[24] H. Ishida,et al. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. , 2000, The Journal of veterinary medical science.
[25] S. Khusmith,et al. Complicated malaria is associated with differential elevations in serum levels of interleukins 10, 12, and 15. , 1999, The Southeast Asian journal of tropical medicine and public health.
[26] Svensson,et al. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. , 1999, The Journal of infectious diseases.
[27] A. Taylor-Robinson,et al. A dichotomous role for nitric oxide in protection against blood stage malaria infection. , 1999, Immunology letters.
[28] Christl A. Donnelly,et al. Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.
[29] J. Stopple,et al. First‐Trimester Human Chorionic Villi Express Both Immunoregulatory and Inflammatory Cytokines: A Role for Interleukin‐10 in Regulating the Cytokine Network of Pregnancy , 1999, American journal of reproductive immunology.
[30] V. Adabayeri,et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria , 1998, The Lancet.
[31] L. Hviid,et al. The Role of Variant-specific Immunity in Asymptomatic Malaria Infections: Maintaining a Fine Balance. , 1998, Parasitology today.
[32] G. Grau,et al. Profiles of cytokine production in relation with susceptibility to cerebral malaria. , 1993, Journal of immunology.
[33] Jaeger,et al. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites , 1992, Infection and immunity.
[34] M. van den Broek,et al. Cytokines inhibit the development of liver schizonts of the malaria parasite plasmodium berghei in vivo , 1992, European journal of immunology.
[35] A. Sher,et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.
[36] S. Reed,et al. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.
[37] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[38] A. Sher,et al. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.
[39] R. Locksley,et al. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[40] V. Nussenzweig,et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.
[41] B. Greenwood,et al. Asymptomatic malaria infections--do they matter? , 1987, Parasitology today.
[42] C. Dye,et al. World Malaria Report, 2008. , 2008 .
[43] S. White,et al. RNAi-mediated chromatin silencing in fission yeast. , 2008, Current topics in microbiology and immunology.
[44] F. Granath,et al. Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. , 2007, Microbes and infection.
[45] P. Kremsner,et al. Uncomplicated malaria. , 2005, Current topics in microbiology and immunology.
[46] Weltgesundheitsorganisation. World malaria report , 2005 .
[47] C. Wongsrichanalai,et al. Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. , 2003, Wiener klinische Wochenschrift.
[48] P. Bloland,et al. Combination therapy for malaria in Africa: hype or hope? , 2000, Bulletin of the World Health Organization.
[49] G. Snounou,et al. Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[50] B. Nahlen,et al. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. , 1999, The Journal of infectious diseases.
[51] C. Rogier,et al. Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[52] 北林 淳. Granulocyte Colony-Stimulating Factor Downregulates Allogeneic Immune Responses by Posttranscriptional Inhibition of Tumor Necrosis Factor-α Production , 1996 .
[53] W. Graninger,et al. Elevated Serum Levels of IL-10 and IFN-γ in Patients with Acute Plasmodium falciparum Malaria , 1995 .
[54] M. Hirokawa,et al. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. , 1995, Blood.